About
Atisama Therapeutics develops splice-switching oligonucleotide therapies to modulate gene transcription, aiming to restore molecular balance and treat chronic inflammatory diseases.
Explore Atisama Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.